Related scientific articles (all)

Vulvar metastasis from bladder cancer.

Authors : Aoun F, El Rassy E, Kourie HR, Hawaux E, Van Velthoven R
Year : 2015
Journal : Case Rep Obstet Gynecol
Volume : 2015
Pages : 324634

Evaluating the pharmacokinetics and pharmacodynamics of everolimus for treating breast cancer.

Authors : Gombos A, Barthélémy P, Awada A
Year : 2015
Journal : Expert Opin Drug Metab Toxicol
Volume : 11(5)
Pages : 823-34.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Authors : Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L
Year : 2015
Journal : Ann Oncol
Volume : 26
Pages : 2408-19

Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?

Authors : Azim HA
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1521-3

New generations of targeted therapies fighting the resistance in solid tumors.

Authors : Barthélémy P, Aftimos P, Awada A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pages : 243-9

What can be learned from our pediatric colleagues?

Authors : Klastersky J
Year : 2015
Journal : Curr Opin Oncol
Volume : 27
Pages : 283-4

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2015
Journal : Am Soc Clin Oncol Educ Book
Volume : 35
Pages : e183-90

Metabolic disorders associated with the use of targeted cancer therapies.

Authors : Kotecki N, Penel N, Awada A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pages : 258-66

Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.

Authors : Gingras I, Azim HA Jr, Ignatiadis M, Sotiriou C
Year : 2015
Journal : Clin Adv Hematol Oncol
Volume : 13
Pages : 372-82

Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors : Coates AS, Winer EP, Goldhirsch A, Gelber Rd, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Year : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1533-46

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Authors : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Year : 2015
Journal : Clin Imaging
Volume : 39(3)
Pages : 454-62

Neoadjuvant Therapy for Breast Cancer.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2015
Journal : Annu. Rev. Med.
Volume : 66
Pages : 31-48

Maastricht delphi consensus on event definitions for classification of recurrence in breast cancer research.

Authors : Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart-Gebhart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML
Year : 2014
Journal : J. Natl. Cancer Inst.
Volume : 106(12)

In times of crisis, go liquid!

Authors : Hendlisz A, Deleporte A, Vandeputte C
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 440

Everolimus plus exemestane as first-line therapy in HR(+), HER2 (-) advanced breast cancer in BOLERO-2.

Authors : Beck JT, Hortobagyi GN, Campone M, Lebrun F, Deleu I, Rugo HS, Pistilli B, Masuda N, Hart L, Melichar B, Dakhil S, Geberth M, Nunzi M, Heng DY, Brechenmacher T, El-Hashimy M, Douma S, Ringeisen F, Piccart-Gebhart M
Year : 2014
Journal : Breast Cancer Res. Treat.
Volume : 143(3)
Pages : 459-67

Biology of breast cancer during pregnancy using genomic profiling.

Authors : Azim HA, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart-Gebhart M, Viale G, Sotiriou C
Year : 2014
Journal : Endocr Relat Cancer
Volume : 21
Pages : 545-54

Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?

Authors : Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Dal Lago L, Repetto L, Ring A, Wildiers H
Year : 2014
Journal : J Geriatr Oncol
Volume : 5(2)
Pages : 204-18

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

Authors : Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, Von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC
Year : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 773-80

Locoregional treatment of breast cancer during pregnancy.

Authors : Toesca A, Gentilini O, Peccatori F, Azim HA, Amant F
Year : 2014
Journal : Gynecol Surg
Volume : 11(4)
Pages : 279-284

Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25.

Authors : Pinto AC, Ferreira-Santos F, Dal Lago L, de Azambuja E, Pimentel FL, Piccart-Gebhart M, Razavi D
Year : 2014
Journal : Ecancermedicalscience
Volume : 8(null)
Pages : 425